Clinical Trials Browser

OTHER_GOV × Colorectal Neoplasms × Levoleucovorin × Clear all

NCT05839470 2023-11-15

Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT03222089 2018-03-27

Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms